We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+5.12%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$5.78B
AUM Growth
+$56.1M
Cap. Flow
-$188M
Cap. Flow %
-3.26%
Top 10 Hldgs %
16.17%
Holding
795
New
72
Increased
310
Reduced
286
Closed
45

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$28.5M
2
META icon
Meta Platforms (Facebook)
META
+$26M
3
TRV icon
Travelers Companies
TRV
+$17.1M
4
LUV icon
Southwest Airlines
LUV
+$16.6M
5
CI icon
Cigna
CI
+$16.6M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$76.5M
2
JNJ icon
Johnson & Johnson
JNJ
+$27.8M
3
GILD icon
Gilead Sciences
GILD
+$26.5M
4
CPB icon
Campbell Soup
CPB
+$20.6M
5
AMZN icon
Amazon
AMZN
+$20.2M

Sector Composition

Rank Sector Weight
1 Healthcare 22.62%
2 Technology 14.65%
3 Financials 14.55%
4 Consumer Discretionary 9.89%
5 Communication Services 9.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PAGP icon
751
Plains GP Holdings
PAGP
$5.23B
– –
-12,720
Closed -$278K
PAM icon
752
Pampa Energía
PAM
$4.64B
– –
-170,000
Closed -$11.1M
P
753
Everpure Inc
P
$24.8B
– –
-243,205
Closed -$3.89M
SJM icon
754
J.M. Smucker
SJM
$12.6B
– –
-9,011
Closed -$946K
SLG icon
755
SL Green Realty
SLG
$3.88B
– –
-2,802
Closed -$275K
SUPN icon
756
Supernus Pharmaceuticals
SUPN
$2.68B
– –
-89,000
Closed -$3.56M
TBPH icon
757
Theravance Biopharma
TBPH
$874M
– –
-20,000
Closed -$685K
TNL icon
758
Travel + Leisure Co
TNL
$4.54B
– –
-86,017
Closed -$4.09M
TTEK icon
759
Tetra Tech
TTEK
$8.23B
– –
-640,000
Closed -$5.96M
WBD icon
760
Warner Bros
WBD
$64.6B
– –
-13,745
Closed -$293K
WRB icon
761
W.R. Berkley
WRB
$28B
– –
-39,113
Closed -$773K
PDCO
762
DELISTED
Patterson Companies, Inc.
PDCO
– –
-11,373
Closed -$440K
KA
763
DELISTED
Kineta, Inc. Common Stock
KA
– –
-536
Closed -$158K
VMW
764
DELISTED
VMware, Inc
VMW
– –
-4,955
Closed -$541K
BBBY
765
DELISTED
Bed Bath & Beyond Inc
BBBY
– –
-19,407
Closed -$455K
SIOX
766
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
– –
-8,625
Closed -$475K
ETFC
767
DELISTED
E*Trade Financial Corporation
ETFC
– –
-5,936
Closed -$259K
ONCE
768
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
– –
-55,000
Closed -$4.9M
MFGP
769
DELISTED
Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share
MFGP
– –
-6,366
Closed -$246K
LNCE
770
DELISTED
Snyders-Lance, Inc.
LNCE
– –
-13,000
Closed -$496K
BWLD
771
DELISTED
Buffalo Wild Wings, Inc.
BWLD
– –
-4,000
Closed -$423K
LVLT
772
DELISTED
Level 3 Communications Inc
LVLT
– –
-34,533
Closed -$1.84M
MACK
773
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
– –
-25,420
Closed -$291K
BCR
774
DELISTED
CR Bard Inc.
BCR
– –
-4,901
Closed -$1.57M
SNC
775
DELISTED
State National Companies, Inc.
SNC
– –
-106,860
Closed -$2.24M
28 29 30
31
32

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2017 Portfolio in Review

As of Q4 2017, Candriam SCA held 795 positions worth $5.78B, up 0.98% from $5.72B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Candriam SCA withdrew a net $188M in Q4 2017, closing 45 positions and reducing 286 holdings. Its most notable exit was Hubbell, an estimated $11.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 27% a quarter earlier, followed by Technology and Financials.

Against the trend, Candriam SCA opened a new position in 58.com Inc worth $15.6M.

  • Candriam SCA's largest Q4 2017 buy was 58.com Inc: 218,000 shares worth $15.6M.
  • Candriam SCA added most to Amgen in Q4 2017, an estimated $28.5M increase.
  • Candriam SCA's biggest Q4 2017 reduction was Biogen, cutting an estimated $76.5M.
  • Candriam SCA fully exited Hubbell in Q4 2017, selling an estimated $11.1M.
  • Candriam SCA's ten largest holdings make up 16% of its $5.78B portfolio in Q4 2017.
  • Candriam SCA opened 72 new positions and closed 45 in Q4 2017.
  • Candriam SCA's portfolio value rose 0.98% quarter-over-quarter to $5.78B.

Based on Candriam SCA's 13F filing for Q4 2017, filed 7 Feb 2018.